Cargando…
Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective
Numerous bacteria utilize molecular communication systems referred to as quorum sensing (QS) to synchronize the expression of certain genes regulating, among other aspects, the expression of virulence factors and the synthesis of biofilm. To achieve this process, bacteria use signaling molecules, kn...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845960/ https://www.ncbi.nlm.nih.gov/pubmed/29563876 http://dx.doi.org/10.3389/fphar.2018.00203 |
_version_ | 1783305513389260800 |
---|---|
author | Rémy, Benjamin Mion, Sonia Plener, Laure Elias, Mikael Chabrière, Eric Daudé, David |
author_facet | Rémy, Benjamin Mion, Sonia Plener, Laure Elias, Mikael Chabrière, Eric Daudé, David |
author_sort | Rémy, Benjamin |
collection | PubMed |
description | Numerous bacteria utilize molecular communication systems referred to as quorum sensing (QS) to synchronize the expression of certain genes regulating, among other aspects, the expression of virulence factors and the synthesis of biofilm. To achieve this process, bacteria use signaling molecules, known as autoinducers (AIs), as chemical messengers to share information. Naturally occurring strategies that interfere with bacterial signaling have been extensively studied in recent years, examining their potential to control bacteria. To interfere with QS, bacteria use quorum sensing inhibitors (QSIs) to block the action of AIs and quorum quenching (QQ) enzymes to degrade signaling molecules. Recent studies have shown that these strategies are promising routes to decrease bacterial pathogenicity and decrease biofilms, potentially enhancing bacterial susceptibility to antimicrobial agents including antibiotics and bacteriophages. The efficacy of QSIs and QQ enzymes has been demonstrated in various animal models and are now considered in the development of new medical devices against bacterial infections, including dressings, and catheters for enlarging the therapeutic arsenal against bacteria. |
format | Online Article Text |
id | pubmed-5845960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58459602018-03-21 Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective Rémy, Benjamin Mion, Sonia Plener, Laure Elias, Mikael Chabrière, Eric Daudé, David Front Pharmacol Pharmacology Numerous bacteria utilize molecular communication systems referred to as quorum sensing (QS) to synchronize the expression of certain genes regulating, among other aspects, the expression of virulence factors and the synthesis of biofilm. To achieve this process, bacteria use signaling molecules, known as autoinducers (AIs), as chemical messengers to share information. Naturally occurring strategies that interfere with bacterial signaling have been extensively studied in recent years, examining their potential to control bacteria. To interfere with QS, bacteria use quorum sensing inhibitors (QSIs) to block the action of AIs and quorum quenching (QQ) enzymes to degrade signaling molecules. Recent studies have shown that these strategies are promising routes to decrease bacterial pathogenicity and decrease biofilms, potentially enhancing bacterial susceptibility to antimicrobial agents including antibiotics and bacteriophages. The efficacy of QSIs and QQ enzymes has been demonstrated in various animal models and are now considered in the development of new medical devices against bacterial infections, including dressings, and catheters for enlarging the therapeutic arsenal against bacteria. Frontiers Media S.A. 2018-03-07 /pmc/articles/PMC5845960/ /pubmed/29563876 http://dx.doi.org/10.3389/fphar.2018.00203 Text en Copyright © 2018 Rémy, Mion, Plener, Elias, Chabrière and Daudé. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Rémy, Benjamin Mion, Sonia Plener, Laure Elias, Mikael Chabrière, Eric Daudé, David Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective |
title | Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective |
title_full | Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective |
title_fullStr | Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective |
title_full_unstemmed | Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective |
title_short | Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective |
title_sort | interference in bacterial quorum sensing: a biopharmaceutical perspective |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845960/ https://www.ncbi.nlm.nih.gov/pubmed/29563876 http://dx.doi.org/10.3389/fphar.2018.00203 |
work_keys_str_mv | AT remybenjamin interferenceinbacterialquorumsensingabiopharmaceuticalperspective AT mionsonia interferenceinbacterialquorumsensingabiopharmaceuticalperspective AT plenerlaure interferenceinbacterialquorumsensingabiopharmaceuticalperspective AT eliasmikael interferenceinbacterialquorumsensingabiopharmaceuticalperspective AT chabriereeric interferenceinbacterialquorumsensingabiopharmaceuticalperspective AT daudedavid interferenceinbacterialquorumsensingabiopharmaceuticalperspective |